Gastrointestinal Cancer
Conference Coverage
One-third of pancreatic cancer diagnoses missed on scans
The time window for curative surgery is often short, and missing the diagnosis can result in worse clinical outcomes.
From the Journals
Sigmoidoscopy screening cuts CRC mortality, incidence
A pooled analysis of four large trials showed a 21% reduction in CRC incidence after sigmoidoscopy screening, compared with usual care.
From the Journals
Colonoscopy lowers CRC risk and death, but not by much: NordICC
In an intention-to-screen analysis, 10-year results from the NordICC trial show that colonoscopy reduces the risk of colorectal cancer by only 18...
From the Journals
Colonoscopy in FIT-based screening demands higher ADR
Endoscopists performing colonoscopy in FIT-positive adults should aim for markedly higher ADRs compared with primary colonoscopy screening,...
From the Journals
AI tool may improve prediction of colorectal cancer recurrence
The QuantCRC algorithm can identify subsets of patients with colorectal cancer who may not need chemotherapy and who may need more intensive...
From the Journals
AGA Clinical Practice Update: Expert review of management of subepithelial lesions
SELs represent a heterogeneous group of lesions such as ectopic pancreatic tissue and tumors, and choice of management depends on several...
From the Journals
Is early-onset cancer an emerging global epidemic?
“This paper ... brings to light the importance of correctable lifestyle habits that may slow the rise of early onset cancers.”
News from the FDA/CDC
FDA approves futibatinib (Lytgobi) for certain biliary tract cancers
Futibatinib is “a key example of the potential of precision medicine” in intrahepatic cholangiocarcinoma.
From the Journals
Risk-adapted screening strategy could reduce colonoscopy use
In countries with limited health care resources, risk-adapted screening strategies could be more cost effective and accessible.
Diminutio
Cancer as a full contact sport
The complexity of cancer care has long necessitated a team approach to planning cancer treatment.
Latest News
Could your patients benefit? New trials in noncolorectal GI cancer
Several new trials have launched.